SP1 and cancer: We have reported that the anti‐cancer drug ISO downregulates Sp1 translation to block BC cell growth and IHC‐P results show Sp1 is upregulated in BBN‐induced BC tissues, suggesting an oncogenic role of Sp1 in BC (Zeng et al., 2016).